BioLineRx Ltd. (BLRX)
Fuera de horario:
BioLineRx Ltd.
Modi’in Technology Park
2 HaMa’ayan Street
Hevel Modi'in 7177871
Israel
972 8 642 9100
https://www.biolinerx.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 79
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Philip A. Serlin CPA, M.B.A., CPA, MBA | Chief Executive Officer | 598k | N/D | 1960 |
| Ms. Mali Zeevi CPA, CPA | Chief Financial Officer | 374k | N/D | 1976 |
| Dr. Ella Sorani Ph.D. | Chief Development Officer | 452k | N/D | 1968 |
| Ms. Holly W. May M.B.A. | President of BioLineRx USA | 710k | N/D | 1962 |
| Mr. John Lacey | Head of Corporate Communications & Investor Relations | N/D | N/D | N/D |
| Ms. Tsipi Keren-Lehrer B.Sc., L.L.B. | Head of BD & Strategic Advisor | N/D | N/D | N/D |
| Mr. Raziel Fried | Treasurer & Budgetary Control Director | N/D | N/D | N/D |
Descripción
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Gestión corporativa
La calificación ISS Governance QuickScore de BioLineRx Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
